SLC6A3 and Parkinson disease: In contrast, in nonhuman primates with experimental parkinsonism, striatal uptake of the DAT ligand did not faithfully reflect nigral cell counts throughout the full range of neuronal loss, with a flooring effect once nigral loss exceeded 50% [69].